Trials / Completed
CompletedNCT01374126
Azithromycin Combination Therapy for the Treatment of Severe Malaria
Azithromycin Combination Therapy for the Treatment of Severe Malaria - A Pilot Safety and Efficacy Study in Uncomplicated Falciparum Malaria in Bangladesh
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 8 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A randomized controlled trial to assess the safety and efficacy of azithromycin combination therapy for use in severe malaria. This pilot trial will be conducted in uncomplicated malaria patients in southeastern Bangladesh.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Artesunate | Artesunate alone |
| DRUG | Azithromycin + Artesunate | Combination of azithromycin + artesunate |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2011-06-15
- Last updated
- 2013-08-23
Locations
1 site across 1 country: Bangladesh
Source: ClinicalTrials.gov record NCT01374126. Inclusion in this directory is not an endorsement.